The Emerging Role of Dyslipidemia in Diabetic Microvascular Complications
Explore this paper's citation graph
Summary
Recent advancements in understanding of the impact of dyslipidemia on microvascular complications in type 2 diabetes (T2D), with an emphasis on peripheral neuropathy (PN) and nephropathy, are summarized.
- Type
- article
- Published
- 2020-02-18
- Cited by
- 53
- References
- 80
- OpenAlex
- https://openalex.org/W32073426
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:211193192
Keywords
Vitamin D and neurology, Calcium, Dietary Reference Intake, Food science, Medicine
References
- Long-term Effects of Lifestyle Intervention or Metformin on Diabetes Development and Microvascular Complications: the DPP Outcomes Study
- CLONAZEPAM FOR NEUROPATHIC PAIN AND FIBROMYALGIA IN ADULTS
- Diabetic Neuropathy
- Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy
- Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study
- Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies
- Reduction in the Incidence of Type 2 Diabetes With the Mediterranean Diet
- Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As
- The Metabolic Syndrome and Microvascular Complications in a Murine Model of Type 2 Diabetes
- Diet and exercise in type 2 diabetes mellitus.
- Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review
- Diabetic Kidney Disease in Adolescents with Type 2 Diabetes: New Insights and Potential Therapies
- Metabolic Syndrome Components Are Associated With Symptomatic Polyneuropathy Independent of Glycemic Status
- Targeting inflammation in diabetic kidney disease: early clinical trials
- Metabolic Effects of Monounsaturated Fatty Acid–Enriched Diets Compared With Carbohydrate or Polyunsaturated Fatty Acid–Enriched Diets in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials
- Association Between Metabolic Syndrome Components and Polyneuropathy in an Obese Population.
- Fatty acid intake and its dietary sources in relation with markers of type 2 diabetes risk: The NEO study
- Diabetic Neuropathy: A Position Statement by the American Diabetes Association
- Kidney disease and obesity: epidemiology, mechanisms and treatment
- Mediators of diabetic neuropathy - is hyperglycemia the only culprit?
Cited by
- Molecular complexities underlying the vascular complications of diabetes mellitus - A comprehensive review.
- Evolving concepts on the role of dyslipidemia, bioenergetics, and inflammation in the pathogenesis and treatment of diabetic peripheral neuropathy
- Kidney Adaptations Prevent Loss of Trace Elements in Wistar Rats with Early Metabolic Syndrome
- IDOL gene variant is associated with hyperlipidemia in Han population in Xinjiang, China
- Diabetic neuropathy in children and youth: new and emerging risk factors
- Sex differences in insulin resistance, but not peripheral neuropathy, in a diet-induced prediabetes mouse model
- High Dietary Fat Consumption Impairs Axonal Mitochondrial Function In Vivo
- Use of Network Pharmacology to Explore the Mechanism of Gegen (Puerariae lobatae Radix) in the Treatment of Type 2 Diabetes Mellitus Associated with Hyperlipidemia
- Plasma lipid metabolites associate with diabetic polyneuropathy in a cohort with type 2 diabetes
- Causal Associations Between Blood Lipids and COVID-19 Risk: A Two-Sample Mendelian Randomization Study
- Prognostic models of diabetic microvascular complications: a systematic review and meta-analysis
- Dietary weight loss in the severely obese stabilizes neuropathy and improves symptomatology
- The Impact of Incretin-Based Medications on Lipid Metabolism
- A Role for Fatty Acids in Peripheral Neuropathy Associated with Type 2 Diabetes and Prediabetes
- Lipid variability and risk of microvascular complications in Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: A post hoc analysis
- Soluble Epoxide Hydrolase and Diabetes Complications
- Risk Factors of Microvascular Complications Among Type 2 Diabetic Patients Using Cox Proportional Hazards Models: A Cohort Study in Tabuk Saudi Arabia
- Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes
- Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments
- Predictive Value of the Advanced Lipoprotein Profile and Glycated Proteins on Diabetic Retinopathy
Related papers
- Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.
- Vitamin D deficiency.
- The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
- Clinician’s Guide to Prevention and Treatment of Osteoporosis
- Vitamin D: The calcium homeostatic steroid hormone
- Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial.
- Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease.
- Decreased bioavailability of vitamin D in obesity.
- Vitamin D Deficiency and Risk of Cardiovascular Disease